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Objectives: Optimization of drugs use could be achieved
only at full understanding of their speciﬁc pharmacological
effects in human organism. Our aim was to investigate
wide spectra of biologic activities of immunomodulators
Epobiocrin (Epoetin alfa, Biopharma, Ukraine) and
Neupogen (Filgrastimum, Roche, Switzerland) with new
complex model of neutropenia and anemia in vivo.
Methods: Albino female mice were divided into four
groups. Animals of groups I-III received vincristine sulfate
intraperitoneally at a dose of 0.52mg/kg b.w./day, twice,
at 1 and 8 days of experiment (for neutropenia and
anemia modelling). Among this, mice from group II
received subcutaneously Epobiocrin 3780 IU/kg b.w./day
8 injections with 48 hour intervals, mice from group III
received subcutaneously Neupogen 0.126mg/kg b.w./day
14 injections with 24 hour intervals. The positive control
group (IV) was composed of intact animals. At 15 day
of experiment animals were sacriﬁced and their blood
and spleens were investigated. Hematological studies
were carried out with hematological analyzer MYTHIC 22
(C2Diagnostics, France).
Results: As a result of our experiments was created
new complex model of neutropenia and anemia with use
of vincristine sulfate in dose of 1/10 LD50, which was
inferior to none of previously used models in respect of
pathologic changes rates and their statistic signiﬁcance. Its
positive advantages were lower quantity of preparation
and possibility to regulate required levels of pathology
manifestation. With our combined model of anemia and
neutropenia both Epobiocrin and Neupogen demonstrated
ability to stimulate erythropoiesis (increase of erythrocytes
number, hemoglobin level, spleen mass coefﬁcient) and
leukopoiesis (increase of neutrophils level) in comparison
with group I.
Conclusion: Thus use of our model allowed to demonstrate
that preparations are regulators both erythropoiesis and
leukopoiesis which must be taken into account in medicine
at immunocorrection treatment.
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Background: Insulin-like growth factor-I receptor (IGF-IR)
which highly expression in the embryonic period in vivo
and Maintain a low concentration levels in adulthood. As an
important mediated factor IGF-IR take part in the regulation
of cell growth, differentiation and proliferation. It also
mediates mitogen signal, anti-apoptotic, induce vascular
endothelial growth factor (VEGF) and necessity for cell
type transformation. We investigated the expression and
its clinical pathological alteration of IGF-IR in different
parts of human hepatocellular carcinoma (HCC) and its
paracancerous tissues.
Methods: Using the immunohistochemistry and nested-PCR
assay, IGF-IR and IGF-1R gene expression was detected in
30 HCC and their non-cancerous tissues. The relationship
between IGF-IR and IGF-II or their clinical pathological
characteristics was investigated.
Results: The stronger expression of IGF-IR was found in
either HCC or non-cancerous tissues. The positive rate of
IGF-IR expression was 80.0% in HCC tissues, and 43.3% in
non-cancerous tissues, respectively. A signiﬁcant difference
was present between them (c2 = 8.53, P < 0.01). The positive
expression of IGF-IR in HCC was correlated to tumor
differentiation, but not to tumor number, size, HBsAg and
AFP. The expressions of IGF-IR and IGF-II in HCC were
of positive correlation. The level of IGF-IR expression
was positively correlated with the corresponding degree
of differentiation for which the incidence was 44.4% in
the high differentiation group, 92.9% in the moderate
differentiation, and 100% in the low differentiation group
(Fisher’s exact test). The IGF-IR and IGF-II expressed of
moderate and low differentiation of HCC are more than high
differentiation ones signiﬁcantly, and they also had positive
correlation in different degree of differentiation (P < 0.05).
Conclusion: The overexpression of hepatic IGF-IR was
associated with the occurrence and development of HCC.
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Background: It has been demonstrated that TGF-b1 played
a key role in HSCs activation through interaction with b-
catenin. This study was designed to elucidate the molecular
mechanism involved in the effect of inhibition of b-catenin
on TGF-b1 induced HSCs activation.
Methods: HSC-T6 cells were transfected with pEGFP-C1-
Dickkopf-1 (DKK-1, experiment group) and pEGFP-C1-neo
(control group), while the normal group received PBS
instead of DKK-1. All cells without the normal group were
incubated with 1 ng/ml TGF-b1 for 2 hours. At the end of
the experiment, the mRNA and protein levels of smad3,
b-catenin and a-SMA in cells were analyzed via RT-PCR and
western-blot.
Results: Both mRNA and protein levels of b-catenin and
a-SMA in HSCs were signiﬁcantly increased by TGF-b1
in control group compared with normal group, whereas
DKK-1 markedly reduced all the above parameters (p < 0.05,
respectively). Moreover, DKK-1 signiﬁcantly decreased the
cell viability of HSC-T6 cells compared with control group.
Figure 1. Transfection of DKK-1.
